Back أفليبيرسيبت Arabic Aflibercept German Aflibercept English Aflibercept Spanish افلیبرسپت Persian Aflibercept French אפליברספט HE Aflibercept Italian アフリベルセプト Japanese Aflibercept Dutch
| Klinički podaci | |
|---|---|
| Robne marke | Eylea, Zaltrap |
| AHFS/Drugs.com | Monografija |
| Identifikatori | |
| CAS broj | 862111-32-8 |
| ATC kod | S01LA05 |
| DrugBank | DB08885 |
| Hemijski podaci | |
| Formula | C4318H6788N1164O1304S32 |
| Mol. masa | 96.90 kDa |
| Farmakokinetički podaci | |
| Poluvreme eliminacije | 7,13 dana |
| Farmakoinformacioni podaci | |
| Trudnoća | ? |
| Pravni status | |
| Način primene | Intraokularno |
Aflibercept je rekombinantni fuzioni protein koji se sastoji od dve glavne komponente: vezujućeg dela vaskularnog endotelnog faktora rasta (VEGF) iz ekstracelularnih domena ljudskih VEGF receptora 1 i 2, koji su spojeni sa Fc porcijom ljudskog IgG1. Aflibercept je oftalmički agens, koji se koristi u lečenju makularnog edema nakon centralne retinalne venske okcluzije (CRVO) i neovaskularne starosne makularne degeneracije (AMD). FDA je odobrila primenu ovog leka novembera 2011 a EMA novembera 2012.[1][2][3][4]
- ↑ Freund KB, Mrejen S, Gallego-Pinazo R: An update on the pharmacotherapy of neovascular age-related macular degeneration. Expert Opin Pharmacother. 2013 Jun;14(8):1017-28. doi: 10.1517/14656566.2013.787410. Epub 2013 Apr 8. PMID 23560774
- ↑ Thai HT, Veyrat-Follet C, Mentre F, Comets E: Population pharmacokinetic analysis of free and bound aflibercept in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2013 May 15. PMID 23673444
- ↑ Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035-41. DOI:10.1093/nar/gkq1126. PMC 3013709. PMID 21059682.
- ↑ David S. Wishart, Craig Knox, An Chi Guo, Dean Cheng, Savita Shrivastava, Dan Tzur, Bijaya Gautam, and Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Res 36 (Database issue): D901-6. DOI:10.1093/nar/gkm958. PMC 2238889. PMID 18048412.